These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2620122)

  • 1. [Intravenous adriamycin in ambulatory patients: value of an optimal planification of sampling times combined with a Bayesian evaluation of pharmacokinetic parameters].
    Launay MC; Milano G; Iliadis A; Frenay M
    Bull Cancer; 1989; 76(8):903-4. PubMed ID: 2620122
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.
    Bos AM; Boom K; Vinks AA; Boezen HM; Wanders J; Dombernovsky P; Aamdal S; de Vries EG; Uges DR
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):64-70. PubMed ID: 15069581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients.
    Launay MC; Milano G; Iliadis A; Frenay M; Namer N
    Br J Cancer; 1989 Jul; 60(1):89-92. PubMed ID: 2803920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bayesian estimation of pharmacokinetic parameters of etoposide].
    Evene E; Chatelut E; Tranchand B; Canal P; Lochon I; Iliadis A; Ardiet CJ
    Bull Cancer; 1997 Jul; 84(7):699-703. PubMed ID: 9339195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
    Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
    Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative intra-arterial infusion chemotherapy in locally advanced primary breast cancer-tissue concentrations of 5-fluorouracil and adriamycin, and the histological evaluation].
    Ishikawa H; Murayama N; Kasahara M; Ikoma M; Takenaka Y; Yoshida H; Shimada A; Watanabe M
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2911-6. PubMed ID: 3140732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adriamycin in the combined chemotherapy of metastatic breast cancer].
    Izmaĭlova GE; Letiagin VP
    Vestn Akad Med Nauk SSSR; 1986; (5):47-51. PubMed ID: 3727784
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histopathological evaluation of transarterial one shot infusion of adriamycin as a preoperative adjuvant chemotherapy for the breast cancer].
    Fukuda K; Kato G; Sawai K; Tokuda H; Takahashi T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):273-7. PubMed ID: 6881977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma.
    Holmes FA
    Semin Oncol; 1995 Aug; 22(4 Suppl 8):9-15. PubMed ID: 7543702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study.
    Bottomley A; Biganzoli L; Cufer T; Coleman RE; Coens C; Efficace F; Calvert HA; Gamucci T; Twelves C; Fargeot P; Piccart M;
    J Clin Oncol; 2004 Jul; 22(13):2576-86. PubMed ID: 15226325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of doxorubicin cardiotoxicity by the bispiperazinedione ICRF-187 in women with advanced breast cancer: a preliminary report.
    Jurga L; Misurová E; Vancík J
    Neoplasma; 1993; 40(4):259-62. PubMed ID: 8272153
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on patients with advanced and recurrent breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1669-74. PubMed ID: 6591857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ongoing European organization for research and treatment of cancer crossover trial comparing single-agent paclitaxel and doxorubicin as first- and second-line treatment of advanced breast cancer.
    Piccart-Gebhart MJ; Bruning P; Gamucci T; Klijn J; Roy JA; Awada A; Kusenda Z; Van Vreckem A; Paridaens R
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):11-5. PubMed ID: 8893893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer].
    Gershanovich ML; Moiceenko VM; Orlova RV
    Vopr Onkol; 1993; 39(1-3):26-32. PubMed ID: 8073671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach.
    Bolon M; Bastien O; Flamens C; Paulus S; Salord F; Boulieu R
    J Pharm Pharmacol; 2003 Jun; 55(6):765-71. PubMed ID: 12841936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adriamycin in a 24-hour continuous venous infusion combined with vincristine in advanced breast carcinoma].
    Rabinovich MG; Leone BA
    Medicina (B Aires); 1982; 42(6 Pt 2):959-60. PubMed ID: 7169949
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
    Tashiro H; Takahashi I; Yamamura S; Ishikawa T; Yanaga K; Wakasugi K; Matsusaka T; Kume K
    Gan To Kagaku Ryoho; 1999 May; 26(6):775-9. PubMed ID: 10410146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I-II study of pegylated liposomal doxorubicin combined with weekly paclitaxel as first-line treatment in patients with metastatic breast cancer.
    Bourgeois H; Ferru A; Lortholary A; Delozier T; Boisdron-Celle M; Abadie-Lacourtoisie S; Joly F; Chieze S; Chabrun V; Gamelin E; Tourani JM
    Am J Clin Oncol; 2006 Jun; 29(3):267-75. PubMed ID: 16755180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adriamycin/cyclophosphamide: current standard in adjuvant therapy for breast carcinoma?].
    Sauter C
    Schweiz Med Wochenschr; 1994 Oct; 124(43):1879-81. PubMed ID: 7973513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.